Q2 EPS Estimates for HCA Healthcare Boosted by Analyst

HCA Healthcare, Inc. (NYSE:HCA) – Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of HCA Healthcare in a research note issued to investors on Wednesday, October 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $6.53 per share for the quarter, up from their prior forecast of $6.52. The consensus estimate for HCA Healthcare’s current full-year earnings is $22.48 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q3 2025 earnings at $5.77 EPS, Q4 2025 earnings at $7.44 EPS and FY2025 earnings at $25.79 EPS.

A number of other analysts also recently issued reports on HCA. Oppenheimer raised their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Wells Fargo & Company increased their target price on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 22nd. Finally, Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five analysts have rated the stock with a hold rating, twelve have assigned a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $377.17.

HCA Healthcare Trading Down 8.9 %

Shares of NYSE HCA opened at $363.55 on Friday. The stock has a market capitalization of $93.82 billion, a P/E ratio of 17.07, a PEG ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The business’s 50 day moving average is $395.06 and its two-hundred day moving average is $352.71. HCA Healthcare has a 1-year low of $220.55 and a 1-year high of $417.14.

Institutional Trading of HCA Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of HCA. Terra Nova Asset Management LLC boosted its stake in shares of HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its holdings in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares in the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares during the period. Brookstone Capital Management raised its position in shares of HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the period. Finally, UMB Bank n.a. increased its stake in shares of HCA Healthcare by 2.4% in the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,345 shares of company stock worth $5,747,945. Insiders own 1.60% of the company’s stock.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.73%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 12.39%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.